Current advances in the diagnosis and treatment of nonerosive reflux disease

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Chen, Chien Lin ^a   Hsu, Ping I ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; RABEPRAZOLE;

ESOPHAGEAL PH MONITORING; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; IMPEDANCE; MEDICAL HISTORY; NON EROSIVE REFLUX DISEASE; PATHOGENESIS; PREVALENCE; REFLUX ESOPHAGITIS; REVIEW; RISK FACTOR;

EID: 84880890594     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/653989     Document Type: Review

References (76)

1. Vakil N., van Zanten S. V., Kahrilas P., Dent J., Jones R., Bianchi L. K., Cesario K. B., The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. American Journal of Gastroenterology 2006 101 8 1900 1943 2-s2.0-33746709974 10.1111/j.1572-0241.2006.00630.x (Pubitemid 44166604)
2. Moayyedi P., Talley N. J., Gastro-oesophageal reflux disease. The Lancet 2006 367 9528 2086 2100 2-s2.0-33745195704 10.1016/S0140-6736(06)68932-0
3. Fock K. M., Talley N. J., Fass R., Goh K. L., Katelaris P., Hunt R., Hongo M., Ang T. L., Holtmann G., Nandurkar S., Lin S. R., Wong B. C. Y., Chan F. K. L., Rani A. A., Bak Y.-T., Sollano J., Ho L. K. Y., Manatsathit S., Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. Journal of Gastroenterology and Hepatology 2008 23 1 8 22 2-s2.0-37249000857 10.1111/j.1440-1746.2007.05249.x (Pubitemid 350265214)
4. Wiklund I., Review of the quality of life and burden of illness in gastroesophageal reflux disease. Digestive Diseases 2004 22 2 108 114 2-s2.0-4644242302 10.1159/000080308 (Pubitemid 39274305)
5. El-Serag H. B., Epidemiology of non-erosive reflux disease. Digestion 2008 78 supplement 1 6 10 2-s2.0-53349142040 10.1159/000151249
6. Modlin I. M., Hunt R. H., Malfertheiner P., Moayyedi P., Quigley E. M., Tytgat G. N. J., Tack J., Heading R. C., Holtman G., Moss S. F., Diagnosis and management of non-erosive reflux disease-the vevey NERD consensus group. Digestion 2009 80 2 74 88 2-s2.0-67449126741 10.1159/000219365
7. Lind T., Havelund T., Carlsson R., Anker-Hansen O., Glise H., Hernqvist H., Junghard O., Lauritsen K., Lundell L., Pedersen S.-A., Stubberöd A., Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scandinavian Journal of Gastroenterology 1997 32 10 974 979 2-s2.0-15444356140 (Pubitemid 27433659)
8. Dean B. B., Gano A. D. Jr., Knight K., Ofman J. J., Fass R., Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clinical Gastroenterology and Hepatology 2004 2 8 656 664 2-s2.0-3543024548 10.1016/S1542-3565(04)00288-5 (Pubitemid 39013424)
9. Fass R., Fennerty M. B., Vakil N., Nonerosive reflux disease-current concepts and dilemmas. American Journal of Gastroenterology 2001 96 2 303 314 2-s2.0-0035120362 10.1016/S0002-9270(00)02304-2 (Pubitemid 32184912)
10. Richter J. E., Castell D. O., Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Annals of Internal Medicine 1982 97 1 93 103 2-s2.0-0019992430 (Pubitemid 12091288)
11. Fass R., Tougas G., Functional heartburn: the stimulus, the pain, and the brain. Gut 2002 51 6 885 892 2-s2.0-0036893791 10.1136/gut.51.6.885 (Pubitemid 35408615)
12. The Rome International Working Teams, Drossman D. A., Corazziari E., Talley N. J., Functional heartburn. Rome II: the Functional Gastrointestinal Disorders 2000 Lawrence, Allen Press 275 278
13. Savarino E., Zentilin P., Tutuian R., Pohl D., Casa D. D., Frazzoni M., Cestari R., Savarino V., The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. American Journal of Gastroenterology 2008 103 11 2685 2693 2-s2.0-55349114697 10.1111/j.1572-0241. 2008.02119.x
14. Hershcovici T., Fass R., Nonerosive Reflux Disease (NERD)-an update. Neurogastroenterology & Motility 2010 16 1 8 21
15. Winter J. W., Heading R. C., The nonerosive reflux disease- gastroesophageal reflux disease controversy. Current Opinion in Gastroenterology 2008 24 4 509 515 2-s2.0-66349124792 10.1097/MOG.0b013e3283025c57
16. Isolauri J., Luostarinen M., Isolauri E., Reinikainen P., Viljakka M., Keyriläinen O., Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. American Journal of Gastroenterology 1997 92 1 37 41 2-s2.0-0031022019 (Pubitemid 27027025)
17. Kuster E., Ros E., Toledo-Pimentel V., Pujol A., Bordas M., Grande L., Pera C., Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut 1994 35 1 8 14 2-s2.0-0028058216
18. Sontag S., Schnell T., Chejfec G., Metz A., Sonnenberg A., The benign natural history of GERD: 20 years with rare serious progression. American Journal of Gastroenterology 1999 94. abstract 2604
19. Manabe N., Yoshihara M., Sasaki A., Tanaka S., Haruma K., Chayama K., Clinical characteristics and natural history of patients with low-grade reflux esophagitis. Journal of Gastroenterology and Hepatology 2002 17 9 949 954 2-s2.0-0036379773 10.1046/j.1440-1746.2002.02783.x
20. Labenz J., Nocon M., Lind T., Leodolter A., Jaspersen D., Meyer-Sabellek W., Stolte M., Vieth M., Willich S. N., Malfertheiner P., Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. American Journal of Gastroenterology 2006 101 11 2457 2462 2-s2.0-33750520550 10.1111/j.1572-0241.2006.00829.x (Pubitemid 44665238)
21. Galmiche J.-P., Barthelemy P., Hamelin B., Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Alimentary Pharmacology and Therapeutics 1997 11 4 765 773 2-s2.0-0030883417 (Pubitemid 27376366)
22. Carlsson R., Dent J., Watts R., Riley S., Sheikh R., Hatlebakk J., Haug K., De Groot G., Van Oudvorst A., Dalväg A., Junghard O., Wiklund I., Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. European Journal of Gastroenterology and Hepatology 1998 10 2 119 124 2-s2.0-19244380563 (Pubitemid 28101879)
23. Robinson M., Earnest D., Rodriguez-Stanley S., Greenwood-Van Meerveld B., Jaffe P., Silver M. T., Kleoudis C. S., Wilson L. E., Murdoch R. H., Heartburn requiring frequent antacid use may indicate significant illness. Archives of Internal Medicine 1998 158 21 2373 2376 2-s2.0-0032561660 (Pubitemid 28536491)
24. Rosaida M. S., Goh K.-L., Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study. European Journal of Gastroenterology and Hepatology 2004 16 5 495 501 2-s2.0-2342449947 10.1097/00042737-200405000-00010 (Pubitemid 38586479)
25. Wu J. C. Y., Cheung C. M. Y., Wong V. W. S., Sung J. J. Y., Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Clinical Gastroenterology and Hepatology 2007 5 6 690 695 2-s2.0-34249736993 10.1016/j.cgh.2007.02.023 (Pubitemid 46830055)
26. Emerenziani S., Ribolsi M., Sifrim D., Blondeau K., Cicala M., Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Neurogastroenterology & Motility 2009 21 3 253 258 2-s2.0-60649094597 10.1111/j.1365-2982.2008.01203.x
27. Ho K. Y., Kang J. Y., Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere. American Journal of Gastroenterology 1999 94 5 1186 1191 2-s2.0-0033135532 10.1111/j.1572-0241.1999.01063.x (Pubitemid 29214625)
28. Martinez S. D., Malagon I. B., Garewal H. S., Cui H., Fass R., Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Alimentary Pharmacology and Therapeutics 2003 17 4 537 545 2-s2.0-0037441247 10.1046/j.1365-2036.2003.01423.x (Pubitemid 36384812)
29. Shapiro M., Green C., Faybush E. M., Esquivel R. F., Fass R., The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Alimentary Pharmacology and Therapeutics 2006 23 2 321 329 2-s2.0-33644903474 10.1111/j.1365-2036.2006.02747.x (Pubitemid 43382043)
30. Bredenoord A. J., Hemmink G. J. M., Smout A. J. P. M., Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterology & Motility 2009 21 8 807 812 2-s2.0-68249106833 10.1111/j.1365-2982.2009.01306.x
31. Dickman R., Bautista J. M., Wong W.-M., Bhatt R., Beeler J. N., Malagon I., Risner-Adler S., Lam K.-F., Fass R., Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. American Journal of Gastroenterology 2006 101 11 2463 2469 2-s2.0-33750504029 10.1111/j.1572-0241.2006.00944.x (Pubitemid 44665239)
32. Bredenoord A. J., Weusten B. L. A. M., Curvers W. L., Timmer R., Smout A. J. P. M., Determinants of perception of heartburn and regurgitation. Gut 2006 55 3 313 318 2-s2.0-33144464767 10.1136/gut.2005.074690 (Pubitemid 43268266)
33. Zerbib F., Duriez A., Roman S., Capdepont M., Mion F., Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 2008 57 2 156 160 2-s2.0-38549088902 10.1136/gut.2007.133470 (Pubitemid 351158039)
34. Emerenziani S., Sifrim D., Habib F. I., Ribolsi M., Guarino M. P. L., Rizzi M., Caviglia R., Petitti T., Cicala M., Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 2008 57 4 443 447 2-s2.0-41149095043 10.1136/gut.2007.130104 (Pubitemid 351442524)
35. Ang D., Sifrim D., Tack J., Mechanisms of heartburn. Nature Clinical Practice Gastroenterology and Hepatology 2008 5 7 383 392 2-s2.0-47249083793 10.1038/ncpgasthep1160 (Pubitemid 351984294)
36. van Malenstein H., Farré R., Sifrim D., Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. American Journal of Gastroenterology 2008 103 4 1021 1028 2-s2.0-41849125260 10.1111/j.1572-0241. 2007.01688.x (Pubitemid 351501085)
37. Caviglia R., Ribolsi M., Maggiano N., Gabbrielli A. M., Emerenziani S., Guarino M. P. L., Carotti S., Habib F. I., Rabitti C., Cicala M., Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. American Journal of Gastroenterology 2005 100 3 543 548 2-s2.0-20144388598 10.1111/j.1572-0241.2005. 40978.x (Pubitemid 40487550)
38. Calabrese C., Bortolotti M., Fabbri A., Areni A., Cenacchi G., Scialpi C., Miglioli M., Di Febo G., Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. American Journal of Gastroenterology 2005 100 3 537 542 2-s2.0-16844376429 10.1111/j.1572-0241.2005. 40476.x (Pubitemid 40487549)
39. Calabrese C., Fabbri A., Bortolotti M., Cenacchi G., Areni A., Scialpi C., Miglioli M., Di Febo G., Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Alimentary Pharmacology and Therapeutics 2003 18 5 525 532 2-s2.0-0141740549 10.1046/j.1365-2036.2003.01713.x (Pubitemid 37152293)
40. Farré R., De Vos R., Geboes K., Verbecke K., Berghe P. V., Depoortere I., Blondeau K., Tack J., Sifrim D., Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 2007 56 9 1191 1197 2-s2.0-34548125019 10.1136/gut.2006.113688 (Pubitemid 47300417)
41. Bhat Y. M., Bielefeldt K., Capsaicin receptor (TRPV1) and non-erosive reflux disease. European Journal of Gastroenterology and Hepatology 2006 18 3 263 270 2-s2.0-33644603970 10.1097/00042737-200603000-00006
42. Sarkar S., Hobson A. R., Hughes A., Growcott J., Woolf C. J., Thompson D. G., Aziz Q., The prostaglandin E2 receptor-1 (EP-1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 2003 124 1 18 25 2-s2.0-0037220693 10.1053/gast.2003.50022 (Pubitemid 36055334)
43. Anand P., Aziz Q., Willert R., van Oudenhove L., Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterology & Motility 2007 19 1, supplement 29 46 2-s2.0-33846077125 10.1111/j.1365-2982. 2006.00873.x (Pubitemid 46058981)
44. Fass R., Naliboff B. D., Fass S. S., Peleg N., Wendel C., Malagon I. B., Mayer E. A., The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology 2008 134 3 696 705 2-s2.0-39749125041 10.1053/j.gastro.2007.12.010 (Pubitemid 351312725)
45. Schey R., Dickman R., Parthasarathy S., Quan S. F., Wendel C., Merchant J., Powers J., Han B., van Handel D., Fass R., Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 2007 133 6 1787 1795 2-s2.0-36549029344 10.1053/j.gastro.2007.09.039 (Pubitemid 350180819)
46. Yi C.-H., Hu C.-T., Chen C.-L., Sleep dysfunction in patients with GERD: erosive versus nonerosive reflux disease. American Journal of the Medical Sciences 2007 334 3 168 170 2-s2.0-34548675174 10.1097/MAJ.0b013e318141f4a5 (Pubitemid 47414989)
47. Zheng Z., Nordenstedt H., Pedersen N. L., Lagergren J., Ye W., Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 2007 132 1 87 95 2-s2.0-33846265369 10.1053/j.gastro.2006.11. 019 (Pubitemid 46108753)
48. Jansson C., Nordenstedt H., Wallander M.-A., Johansson S., Johnsen R., Hveem K., Lagergren J., Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Alimentary Pharmacology and Therapeutics 2007 26 5 683 691 2-s2.0-34547830866 10.1111/j.1365-2036.2007.03411.x (Pubitemid 47246200)
49. Jansson C., Nordenstedt H., Johansson S., Wallander M.-A., Johnsen R., Hveem K., Lagergren J., Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT study). Clinical Gastroenterology and Hepatology 2007 5 9 1029 1034 2-s2.0-35748952848 10.1016/j.cgh.2007.04.009
50. Lee Y.-C., Wang H.-P., Chiu H.-M., Liao S.-C., Huang S.-P., Lai Y.-P., Wu M.-S., Chen M.-F., Lin J.-T., Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. Journal of Gastroenterology and Hepatology 2006 21 5 798 804 2-s2.0-33646898867 10.1111/j.1440-1746.2005.04034.x (Pubitemid 43793274)
51. Nastaskin I., Mehdikhani E., Conklin J., Park S., Pimentel M., Studying the overlap between IBS and GERD: a systematic review of the literature. Digestive Diseases and Sciences 2006 51 12 2113 2120 2-s2.0-33846969213 10.1007/s10620-006-9306-y
52. Pimentel M., Rossi F., Chow E. J., Ofman J., Fullerton S., Hassard P., Lin H. C., Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. Journal of Clinical Gastroenterology 2002 34 3 221 224 2-s2.0-0036181047 10.1097/00004836-200203000-00004 (Pubitemid 34177372)
53. Jung H.-K., Halder S., McNally M., Locke G. R. III, Schleck C. D., Zinsmeister A. R., Talley N. J., Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Alimentary Pharmacology and Therapeutics 2007 26 3 453 461 2-s2.0-34447318410 10.1111/j.1365-2036.2007.03366.x (Pubitemid 47063139)
54. Fass R., Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. Journal of Clinical Gastroenterology 2007 41 2 131 137 2-s2.0-33846444341 10.1097/01.mcg.0000225631.07039.6d (Pubitemid 46148652)
55. Fass R., Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. American Journal of Gastroenterology 2003 98 3, supplement S2 S7 2-s2.0-0037343795 10.1016/S0002-9270(03)00009-1 (Pubitemid 36348509)
56. Smout A. J. P. M., Endoscopy-negative acid reflux disease. Alimentary Pharmacology and Therapeutics 1997 11 supplement 2 81 85 2-s2.0-0030715691 (Pubitemid 27520865)
57. Venables T. L., Newland R. D., Patel A. C., Hole J., Wilcock C., Turbitt M. L., Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scandinavian Journal of Gastroenterology 1997 32 10 965 973 2-s2.0-0030862096 (Pubitemid 27433658)
58. Sharma P., Wani S., Bansal A., Hall S., Puli S., Mathur S., Rastogi A., A feasibility trial of narrow band imaging endoscopy in patients with gastroesophageal reflux disease. Gastroenterology 2007 133 2 454 464 2-s2.0-34547511868 10.1053/j.gastro.2007.06.006 (Pubitemid 47187359)
59. Lee Y.-C., Lin J.-T., Chiu H.-M., Liao W.-C., Chen C.-C., Tu C.-H., Tai C.-M., Chiang T.-H., Chiu Y.-H., Wu M.-S., Wang H.-P., Intraobserver and interobserver consistency for grading esophagitis with narrow-band imaging. Gastrointestinal Endoscopy 2007 66 2 230 236 2-s2.0-34447538087 10.1016/j.gie.2006.10.056 (Pubitemid 47079028)
60. Zerbib F., Roman S., Ropert A., Des Varannes S. B., Pouderoux P., Chaput U., Mion F., Vérin E., Galmiche J.-P., Sifrim D., Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. American Journal of Gastroenterology 2006 101 9 1956 1963 2-s2.0-33748369873 10.1111/j.1572-0241.2006.00711.x (Pubitemid 44337616)
61. Bredenoord A. J., Weusten B. L. A. M., Timmer R., Conchillo J. M., Smout A. J. P. M., Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. American Journal of Gastroenterology 2006 101 3 453 459 2-s2.0-33644782036 10.1111/j.1572-0241.2006.00427.x (Pubitemid 43340918)
62. Gasiorowska A., Fass R., The proton pump inhibitor (PPI) test in GERD: does it still have a role? Journal of Clinical Gastroenterology 2008 42 8 867 874 2-s2.0-54549088750 10.1097/MCG.0b013e31816c47ed
63. 2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database of Systematic Reviews 2004 4 CD002095 2-s2.0-16644382042
64. Bate C. M., Griffin S. M., Keeling P. W. N., Axon A. T. R., Dronfield M. W., Chapman R. W. G., O'Donoghue D., Calam J., Crower J., Mountford R. A., Watts D. A., Taylor M. D., Richardson P. D. I., Reflux symptom relief with omeprazole in patients without unequivocal esophagitis. Alimentary Pharmacology and Therapeutics 1996 10 4 547 555 2-s2.0-9344221689 (Pubitemid 26254798)
65. Miner P. Jr., Orr W., Filippone J., Jokubaitis L., Sloan S., Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. American Journal of Gastroenterology 2002 97 6 1332 1339 2-s2.0-0036084839 10.1016/S0002-9270(02)04125-4 (Pubitemid 34664773)
66. Calabrese C., Liguori G., Gabusi V., Gionchetti P., Rizzello F., Straforini G., Brugnera R., Di Febo G., Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. Alimentary Pharmacology and Therapeutics 2008 28 2 250 255 2-s2.0-45549098809 10.1111/j.1365-2036.2008.03733.x (Pubitemid 351861970)
67. Mönnikes H., Pfaffenberger B., Gatz G., Hein J., Bardhan K. D., Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole. Digestion 2005 71 3 152 158 2-s2.0-21344463807 10.1159/000085576 (Pubitemid 40910935)
68. Kinoshita Y., Ashida K., Hongo M., Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease. Alimentary Pharmacology and Therapeutics 2011 33 2 213 224 2-s2.0-78650293344 10.1111/j.1365-2036.2010.04508.x
69. Gerson L. B., Robbins A. S., Garber A., Hornberger J., Triadafilopoulos G., A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease. American Journal of Gastroenterology 2000 95 2 395 407 2-s2.0-0033970374 10.1016/S0002-9270(99)00818-7 (Pubitemid 30106167)
70. Fass R., Ofman J. J., Gastroesophageal reflux disease-should we adopt a new conceptual framework? American Journal of Gastroenterology 2002 97 8 1901 1909 2-s2.0-0036677469 10.1016/S0002-9270(02)04269-7
71. Bytzer P., Blum A. L., Personal view: rationale and proposed algorithms for symptom-based proton pump inhibitor therapy for gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 2004 20 4 389 398 2-s2.0-4344642267 10.1111/j.1365-2036.2004.02093.x (Pubitemid 39120249)
72. Juul-Hansen P., Rydning A., On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor. Alimentary Pharmacology and Therapeutics 2009 29 2 207 212 2-s2.0-57649166895 10.1111/j.1365-2036.2008.03877.x
73. Fass R., Chey W. D., Zakko S. F., Andhivarothai N., Palmer R. N., Perez M. C., Atkinson S. N., Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease. Alimentary Pharmacology and Therapeutics 2009 29 12 1261 1272 2-s2.0-70349386118 10.1111/j.1365-2036.2009.04013.x
74. Prakash C., Clouse R. E., Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Digestive Diseases and Sciences 1999 44 12 2373 2379 2-s2.0-0033384413 (Pubitemid 30027348)
75. Varia I., Logue E., O'Connor C., Newby K., Wagner H. R., Davenport C., Rathey K., Krishnan K. R., Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. American Heart Journal 2000 140 3 367 372 2-s2.0-0033835589 10.1067/mhj.2000.108514
76. Fenton P., Terry M. L., Galloway K. D., Smith C. D., Hunter J. G., Waring J. P., Is there a role for laparoscopic fundoplication in patients with non-erosive reflux disease (NERD). Gastroenterology 2000 118, supplement 2. abstract A481